Home
About
Overview
Sharing Data
ORCID
Help
History (6)
Committee report: American Pediatrics: milestones at the millennium.
Durable responses in acute lymphoblastic leukaemia with the use of FLT3 and IDH inhibitors.
Management of important adverse events associated with inotuzumab ozogamicin: expert panel review.
Treatment of young adults with Philadelphia-negative acute lymphoblastic leukemia and lymphoblastic lymphoma: Hyper-CVAD vs. pediatric-inspired regimens.
Management of acute lymphoblastic leukemia in young adults.
See All 6 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Management of acute lymphoblastic leukemia in young adults.
Management of acute lymphoblastic leukemia in young adults. Clin Adv Hematol Oncol. 2018 Feb; 16(2):138-146.
View in:
PubMed
subject areas
Adolescent
Adult
Age Factors
Antineoplastic Combined Chemotherapy Protocols
Biomarkers
Combined Modality Therapy
Consolidation Chemotherapy
Disease Management
Genetic Testing
Hematopoietic Stem Cell Transplantation
Humans
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Remission Induction
Salvage Therapy
Treatment Outcome
Young Adult
authors with profiles
Wendy Stock